Creating High Value Sustainable Products Using Synthetic Biology
Calysta is developing proprietary organisms and biocatalysts to economically convert methane to the building blocks of novel nutritional products for fish, livestock and pets. Calysta’s core technology platform, BioGPS™ applies sophisticated machine learning algorithms to describe, design, and optimize complex biological systems.

The company has also developed a suite of unique, market-leading reactor technologies to enable commercial-scale development of the Biological Gas-to-Chemicals® and Biological Gas-to-Liquids® platforms and the Biological Gas to Feed™ fermentation platform. These platforms are enabled by a proprietary combination of biological and chemical engineering technology to create valuable cost and performance advantages over current gas conversion processes. Calysta is developing a broad international portfolio of patents to protect its proprietary technology.